Enrylaze 10 mg/vial, Injektionslösung
7680690730017
CH-69073
Injektionslösung
Associated product:
ENRYLAZE sol inj 10 mg/0.5ml 3 flac 0.5 ml
1 / 3
google
Article details
- Package size
- 3
- Selling units
- 3
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Authorization holder
Jazz Pharmaceuticals
6300 Zug
Authorization information
- Swissmedic authorization number
- 69073
- Drug name
- Enrylaze, Injektionslösung
- Galenic form
- LSIN
- ATC Code
- L01XX02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 18/04/2024
- Authorization expiration date
- 17/04/2029
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- ENRYLAZE sol inj 10 mg/0.5ml 3 flac 0.5 ml
- Description (DE)
- ENRYLAZE Inj Lös 10 mg/0.5ml 3 Durchstf 0.5 ml
- Market launch
- 18/04/2024
- Narcotic (BTM)
- No